As the Demand for a Simplified Multipurpose Specimen Collection Device Grows, More Labs are Validating ESwab™ for use with Molecular Assays

A recent study conducted at Tampa General Hospital in Florida, and published in the Journal of Clinical Microbiology, tested the use of ESwab™ with the BD Max MRSAXT and BD Max StaphSR assays.  The study, consisting of 255 samples collected using ESwab™ showed that the assays have exceptional sensitivity and specificity for detecting MRSA and S. aureus, respectively.

Beckman Coulter Diagnostics and COPAN Announce Expansion of Distribution Agreement for Automated Sample Processing Systems and Digital Microbiology
BREA, CALIF. and MURRIETA, CALIF.  – Beckman Coulter Diagnostics, a global leader in clinical diagnostics, and COPAN, a company committed to innovation in the field of pre-analytics, today announced that Beckman Coulter Diagnostics and COPAN Group have entered into an amendment to their distribution agreement that expands their relationship into new products and geographic territories. Additional products include COPAN’s WASPLab automated, front-end robotic specimen processing, full lab automation and digital microbiology system.

COPAN Unveils COLIBRI™, Universal Colony Picker, during the American Society for Microbiology General Meeting in New Orleans
COPAN Diagnostics, Inc. is pleased to announce the unveiling of the Colibri™ system this week in New Orleans. COPAN is renowned for its forward compatible, flexible and modular approach to total lab automation. Colibri™ is the latest addition to COPAN’s successful line of automation. Colibri™ is an open platform capable of utilizing a diversity of consumables from different suppliers or prepared in house. In keeping with the philosophy of developing open platforms, Colibri™ can work in-line with WASPLab™ or as a standalone workstation to automatically prepare AST and ID suspensions and seed MALDI-TOF target plates with more functionality to come.

COPAN Launches New Website, Offers an Enhanced User Experience and a Modern New Look
COPAN Diagnostics, a company committed to new innovations and education in the field of preanalytics, launches a newly redesigned website. The website Copanusa.com aims to improve COPAN’s online brand and features various enhancements visitors to the site will enjoy.  

COPAN is Proud to Announce FDA Clearance for FecalSwab™ to Standardize and Simplify Enteric Culture and Molecular Diagnostics
COPAN, an innovative company focused on bringing breakthrough products to Microbiology preanalytics around the world, announced that it has obtained FDA clearance for its new FecalSwab™.

Two New US Patents Protect COPAN Invention of Flocked Swabs
The US Patent Office recently granted two additional patents to COPAN regarding flocked swabs. The patent numbers are US 8,979,784 and US 9,011,358, issued on 17th March 2015 and 21st April 2015 respectively. These two patents, are continuations of previous applications related to the flocked swab technology, proudly invented and developed by Copan and dedicated to the collection of biological specimens.